Market Momentum Report: Praxis Precision Medicines Inc (PRAX)’s Negative Close at 70.12

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Praxis Precision Medicines Inc (NASDAQ: PRAX) closed at $70.12 in the last session, down -3.96% from day before closing price of $73.01. In other words, the price has decreased by -$3.96 from its previous closing price. On the day, 0.51 million shares were traded. PRAX stock price reached its highest trading level at $73.83 during the session, while it also had its lowest trading level at $68.42.

Ratios:

We take a closer look at PRAX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.96 and its Current Ratio is at 10.96. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on August 05, 2024, initiated with a Outperform rating and assigned the stock a target price of $134.

On June 24, 2024, Needham started tracking the stock assigning a Buy rating and target price of $145.

On June 18, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $155.Guggenheim initiated its Buy rating on June 18, 2024, with a $155 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 14 ’24 when Nemiroff Alex sold 8,239 shares for $80.20 per share. The transaction valued at 660,827 led to the insider holds 10,301 shares of the business.

Mastrocola Lauren sold 5,188 shares of PRAX for $424,318 on Nov 14 ’24. The Principal Accounting Officer now owns 5,613 shares after completing the transaction at $81.78 per share. On Nov 14 ’24, another insider, Mastrocola Lauren, who serves as the Officer of the company, bought 5,189 shares for $81.77 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRAX now has a Market Capitalization of 1306882560 and an Enterprise Value of 951508928. For the stock, the TTM Price-to-Sale (P/S) ratio is 816.80 while its Price-to-Book (P/B) ratio in mrq is 3.26. Its current Enterprise Value per Revenue stands at 592.84 whereas that against EBITDA is -5.816.

Stock Price History:

Over the past 52 weeks, PRAX has reached a high of $86.93, while it has fallen to a 52-week low of $15.46. The 50-Day Moving Average of the stock is -3.71%, while the 200-Day Moving Average is calculated to be 23.04%.

Shares Statistics:

According to the various share statistics, PRAX traded on average about 325.56K shares per day over the past 3-months and 409000 shares per day over the past 10 days. A total of 17.79M shares are outstanding, with a floating share count of 17.30M. Insiders hold about 7.20% of the company’s shares, while institutions hold 95.25% stake in the company. Shares short for PRAX as of 1732838400 were 1465295 with a Short Ratio of 4.50, compared to 1730332800 on 1724599. Therefore, it implies a Short% of Shares Outstanding of 1465295 and a Short% of Float of 7.870000000000001.

Most Popular